FIELD: medicine.
SUBSTANCE: invention relates to field of medicine. Invention describes application of remyelinating medication for obtaining medication in amount, stimulating remyelination of nerve cells in mammals, for treatment of demyelinating disease and method of stimulating remyelination of nerve cells in mammals, where medication is introduced to constantly demanding it mammal; constant introduction of remyelinating medication represents weekly or monthly introduction during period, equal to, at least, six months; and remyelinating medication represents antibody or its immunologically active enzyme, binding with alfa-4-integrin, and, in particular, antibody represents monoclonal antibody natalizumab or its immunologically active fragment.
EFFECT: application of remyelinating medication for obtaining medication in amount, stimulating remyelination of nerve cells in mammals.
26 cl, 20 tbl, 18 dwg, 381 ex
Title | Year | Author | Number |
---|---|---|---|
CARBAMYLOXY-COMPOUNDS INHIBITING VLA-4-MEDIATED ADHESION OF LEUKOCYTES | 1998 |
|
RU2220964C2 |
ANALOGS OF Δ12,13-ISOTAXOL, INTERMEDIATE COMPOUNDS, METHOD OF SYNTHESIS OF INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2142950C1 |
7-HALO- AND 7β, 8β--METHANOTAXOLS, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS AND METHODS OF SYNTHESIS OF INTERMEDIATE COMPOUNDS | 1993 |
|
RU2125996C1 |
HYDROXYETHYLAMINOSULFONEAMIDES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION RETROVIRAL PROTEASES, METHOD OF TREATMENT OF RETROVIRAL INFECTIONS, METHOD OF TREATMENT OF AIDS | 1993 |
|
RU2173680C2 |
BENZYLPHENYL ETHER DERIVATIVE, METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 2017 |
|
RU2743165C2 |
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS | 2007 |
|
RU2466729C2 |
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS | 2007 |
|
RU2525392C2 |
DERIVATIVES OF 3-[2-(3-ACYLAMINO-2-OXO-2H-PYRIDIN-1-YL)-ACETYLAMINO]-4-OXO-PENTANE ACID AND THEIR APPLICATION AS CASPASE INHIBITORS | 2005 |
|
RU2412936C2 |
PHENYLATE DERIVATIVE, PRODUCTION, PHARMACEUTICAL COMPOSITION AND USE | 2017 |
|
RU2744975C2 |
DERIVATIVES OF N-ACYLPROLYLDIPEPTIDES | 1993 |
|
RU2119496C1 |
Authors
Dates
2011-02-27—Published
2004-01-26—Filed